Comparison of laboratory characteristics between acute promyelocytic leukemia and other subtypes of acute myeloid leukemia with disseminated intravascular coagulation
暂无分享,去创建一个
[1] H. Wada,et al. Diagnostic criteria and laboratory tests for disseminated intravascular coagulation. , 2011, Journal of clinical and experimental hematopathology : JCEH.
[2] M. Höglund,et al. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry , 2011, Leukemia.
[3] F. Santolaria,et al. Prognostic value of inflammatory markers (notably cytokines and procalcitonin), nutritional assessment, and organ function in patients with sepsis. , 2010, European cytokine network.
[4] M. Tallman,et al. How I treat acute promyelocytic leukemia. , 2009, Blood.
[5] J. Esteve,et al. Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin. , 2008, Blood.
[6] Zhen-yi Wang,et al. Acute promyelocytic leukemia: from highly fatal to highly curable. , 2008, Blood.
[7] R. Ribeiro,et al. Clinical features and outcomes of 134 Brazilians with acute promyelocytic leukemia who received ATRA and anthracyclines , 2007, Haematologica.
[8] T. Naoe,et al. Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: incidence, risk factors, and influence on outcome , 2007, European journal of haematology.
[9] M. Yoshioka,et al. Current research on acute phase proteins in veterinary diagnosis: an overview. , 2004, Veterinary journal.
[10] J. Siegel,et al. The relationship between plasma cholesterol, amino acids and acute phase proteins in sepsis , 2004, Amino Acids.
[11] L. Boggio,et al. Abnormalities in hemostasis in acute promyelocytic leukemia , 2002, Hematological oncology.
[12] F B Taylor,et al. Towards Definition, Clinical and Laboratory Criteria, and a Scoring System for Disseminated Intravascular Coagulation , 2001, Thrombosis and Haemostasis.
[13] C. Bloomfield,et al. All-trans-Retinoic Acid in Acute Promyelocytic Leukemia , 2000 .
[14] J. Miguel,et al. A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group. , 1999, Blood.
[15] Y. Miura,et al. Rare but important adverse effects of all-trans retinoic acid in acute promyelocytic leukemia and their management. , 1997, International journal of hematology.
[16] T. Barbui,et al. Early deaths and anti-hemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patients. , 1990, Blood.
[17] B. Clarkson,et al. Acute promyelocytic leukemia: treatment results during a decade at Memorial Hospital. , 1989, Blood.